ArticleCancer medicine2024

Cost-Effectiveness Analysis of Adjuvant Alectinib versus Platinum-Based Chemotherapy in Resected ALK-Positive Non-Small-Cell Lung Cancer in the Chinese Health Care System.

Qiran Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.